Acquired by Amryt (AMYT) in August 2021
CHMA - Chiasma, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Needham,
United States
Type: Equity
CHMA price evolution
CHMA
| (in millions $) | 31 Mar 2021 | 31 Dec 2020 | 30 Sep 2020 | 30 Jun 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $44.85 | $36.02 | $93.14 | $72.19 |
| Short term investments | $90.46 | $119.96 | $83.92 | $14.89 |
| Net receivables | $1.01 | $0.54 | $0.18 | |
| Inventory | $14.38 | $10.96 | $8.94 | |
| Total current assets | $137.03 | $153.36 | $171.26 | $70.83 |
| Long term investments | ||||
| Property, plant & equipment | $0.49 | $0.53 | $0.58 | $0.62 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $22.5 | $22.98 | $23.3 | $23.14 |
| Total investments | $90.46 | $119.96 | $83.92 | $14.89 |
| Total assets | $159.53 | $176.34 | $194.56 | $93.97 |
| Current liabilities | ||||
| Accounts payable | $6.36 | $4.24 | $7.15 | $7.08 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $17.32 | $16.73 | $18.15 | $15.94 |
| Long term debt | ||||
| Total noncurrent liabilities | $79.53 | $67.82 | $66.08 | $26.05 |
| Total debt | ||||
| Total liabilities | $96.85 | $84.55 | $84.22 | $41.99 |
| Shareholders' equity | ||||
| Retained earnings | -$378.26 | -$347.71 | -$327.9 | -$309.45 |
| Other shareholder equity | $0.01 | $0.03 | ||
| Total shareholder equity | $62.69 | $91.78 | $110.34 | $51.98 |
| (in millions $) | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 | 31 Dec 2017 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $36.02 | $27.86 | $13.06 | $14.6 |
| Short term investments | $119.96 | $64.52 | $28.6 | $52.34 |
| Net receivables | $0.54 | |||
| Inventory | $10.96 | |||
| Total current assets | $153.36 | $96.26 | $62.19 | $68.71 |
| Long term investments | ||||
| Property, plant & equipment | $0.53 | $0.33 | $0.11 | $0.19 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $22.98 | $2.57 | $1.07 | $1.18 |
| Total investments | $119.96 | $64.52 | $28.6 | $52.34 |
| Total assets | $176.34 | $98.83 | $63.26 | $69.88 |
| Current liabilities | ||||
| Accounts payable | $4.24 | $3.25 | $2.03 | $1.02 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $16.73 | $11.38 | $28.63 | $6.75 |
| Long term debt | ||||
| Total noncurrent liabilities | $67.82 | $1.68 | $0.51 | $0.66 |
| Total debt | ||||
| Total liabilities | $84.55 | $13.06 | $29.13 | $7.41 |
| Shareholders' equity | ||||
| Retained earnings | -$347.71 | -$272.93 | -$236.61 | -$205.35 |
| Other shareholder equity | $0.04 | -$0.02 | -$0.06 | |
| Total shareholder equity | $91.78 | $85.77 | $34.12 | $62.47 |
| (in millions $) | 31 Mar 2021 | 31 Dec 2020 | 30 Sep 2020 | 30 Jun 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1.92 | $0.96 | $0.14 | |
| Cost of revenue | $0.07 | $0.06 | $0 | |
| Gross Profit | $1.86 | $0.91 | $0.14 | |
| Operating activities | ||||
| Research & development | $4.2 | $4.48 | $4.52 | $9.67 |
| Selling, general & administrative | $15.7 | $13.6 | $13.05 | $10.66 |
| Total operating expenses | $19.9 | $18.08 | $17.57 | $20.34 |
| Operating income | -$18.04 | -$17.17 | -$17.43 | -$20.34 |
| Income from continuing operations | ||||
| EBIT | -$27.62 | -$17 | -$16.31 | -$20.21 |
| Income tax expense | $0.05 | -$0.03 | $0.02 | $0.01 |
| Interest expense | $2.87 | $2.84 | $2.13 | $0.91 |
| Net income | ||||
| Net income | -$30.55 | -$19.81 | -$18.46 | -$21.13 |
| Income (for common shares) | -$30.55 | -$19.81 | -$18.46 | -$21.13 |
| (in millions $) | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 | 31 Dec 2017 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1.11 | |||
| Cost of revenue | $0.06 | |||
| Gross Profit | $1.04 | |||
| Operating activities | ||||
| Research & development | $26.8 | $22.46 | $22.36 | $17.95 |
| Selling, general & administrative | $44.89 | $15.12 | $9.97 | $9.15 |
| Total operating expenses | $71.69 | $37.58 | $32.34 | $28.13 |
| Operating income | -$70.65 | -$37.58 | -$32.34 | -$28.13 |
| Income from continuing operations | ||||
| EBIT | -$68.82 | -$36.04 | -$31.29 | -$27.42 |
| Income tax expense | $0.08 | $0.28 | -$0.03 | -$0.59 |
| Interest expense | $5.87 | |||
| Net income | ||||
| Net income | -$74.78 | -$36.32 | -$31.26 | -$26.83 |
| Income (for common shares) | -$74.78 | -$36.32 | -$31.26 | -$26.83 |
| (in millions $) | 31 Mar 2021 | 31 Dec 2020 | 30 Sep 2020 | 30 Jun 2020 |
|---|---|---|---|---|
| Net income | -$30.55 | -$19.81 | -$18.46 | -$21.13 |
| Operating activities | ||||
| Depreciation | $0.19 | $0.18 | $0.18 | $0.17 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.37 | $1.21 | $1.32 | $1.33 |
| Total cash flows from operations | -$20.64 | -$21.03 | -$25.35 | -$16.36 |
| Investing activities | ||||
| Capital expenditures | -$0 | -$0 | -$0.01 | -$0.07 |
| Investments | $29.42 | -$36.11 | -$69.07 | $21.87 |
| Total cash flows from investing | $29.42 | -$36.12 | -$69.08 | $21.79 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.05 | $0.03 | $75.49 | $0.01 |
| Net borrowings | -$0.33 | |||
| Total cash flows from financing | $0.05 | $0.03 | $115.37 | $24.21 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $8.82 | -$57.12 | $20.95 | $29.64 |
| (in millions $) | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 | 31 Dec 2017 |
|---|---|---|---|---|
| Net income | -$74.78 | -$36.32 | -$31.26 | -$26.83 |
| Operating activities | ||||
| Depreciation | $0.68 | $0.37 | $0.09 | $0.15 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $5.02 | $3.27 | $2.73 | $3.52 |
| Total cash flows from operations | -$75.33 | -$35.01 | -$24.09 | -$24.42 |
| Investing activities | ||||
| Capital expenditures | -$0.37 | -$0.31 | -$0.01 | -$0.02 |
| Investments | -$55.47 | -$35.35 | $24.22 | $3.73 |
| Total cash flows from investing | -$55.84 | -$35.66 | $24.21 | $3.71 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $75.76 | $84.63 | $0.04 | $0 |
| Net borrowings | -$0.84 | $0.84 | ||
| Total cash flows from financing | $139.34 | $85.46 | -$1.66 | -$1.7 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $8.17 | $14.79 | -$1.54 | -$22.41 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 57.89M |
| Revenue | $3.03M |
|---|---|
| EBITDA | -$80.42M |
| EBIT | -$81.14M |
| Net Income | -$89.94M |
| Revenue Q/Q | InfinityT% |
| Revenue Y/Y | N/A |
| P/E ratio | 0.00 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.00 |
| Book/Share | 1.08 |
| Cash/Share | 0.77 |
| EPS | -$1.55 |
|---|---|
| ROA | -57.62% |
| ROE | -113.57% |
| Debt/Equity | 0.92 |
|---|---|
| Net debt/EBITDA | -0.65 |
| Current ratio | 7.91 |
| Quick ratio | 7.08 |